Filing Details
- Accession Number:
- 0001209191-10-015708
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-09 12:00:00
- Reporting Period:
- 2010-03-05
- Filing Date:
- 2010-03-09
- Accepted Time:
- 2010-03-09 17:09:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 887359 | Aastrom Biosciences Inc | ASTM | Biological Products, (No Disgnostic Substances) (2836) | 943096597 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242613 | M Timothy Mayleben | Po Box 376 Ann Arbor MI 48106 | Ceo, President, Cfo & Director | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-03-05 | 17,206 | $1.45 | 18,068 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2010-03-08 | 16,750 | $1.47 | 34,818 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.45 to $1.46, inclusive. The Reporting Person undertakes to provide Aastrom Biosciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
- Reflects a 1-for-8 reverse stock split which became effective on February 18, 2010.
Billionaire Hedge Funds
